Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin
Show more

Phenol API from Switzerland Manufacturers & Suppliers

4 verified results
Get full market intelligence report
Get full market intelligence report
Full access. Full negotiation power All Phenol data. Full access. Full negotiation power

Commercial-scale Suppliers

Producer
Produced in  United Kingdom
|

Employees: 20

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
CoA

All certificates

GMP
CoA
Distributor
Produced in  Switzerland
|

Employees: 135+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
CoA

All certificates

GMP
MSDS
CoA
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Distributor
Produced in  Unknown
|

Employees: 275+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
ISO9001
|
CoA

All certificates

GMP
MSDS
BSE/TSE
ISO9001
CoA
Distributor
Produced in  Germany
|

Employees: 50+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
ISO9001
|
CoA

All certificates

GMP
MSDS
ISO9001
CoA
Get full market intelligence report
Get full market intelligence report
€399,-
All Phenol data. Full access. Full negotiation power
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Phenol | CAS No: 108-95-2 | GMP-certified suppliers

A medication that provides temporary relief of minor sore throat, mouth irritation, canker sore discomfort, and supports controlled clinical management of focal spasticity.

Therapeutic categories

AnestheticsAnesthetics, LocalAnti-Infective AgentsAnti-Infective Agents, LocalAntiseptics and DisinfectantsAntivaricose Therapy
Generic name
Phenol
Molecule type
small molecule
CAS number
108-95-2
DrugBank ID
DB03255
Approval status
Approved drug, Experimental drug
ATC code
C05BB05

Primary indications

  • Phenol is primarily indicated for minor sore throat pain, sore mouth, minor mouth irritation, and pain associated with canker sores
  • Additionally, phenol is indicated in the treatment of focal spasticity

Product Snapshot

  • Phenol is a small‑molecule active available in multiple topical, oral, and injectable formulations
  • It is used for local pain relief in minor oral and oropharyngeal irritation and for certain focal spasticity applications
  • It is approved in the US and Canada, with some uses classified as experimental

Clinical Overview

Phenol (CAS 108-95-2) is an aromatic compound used in pharmaceutical and healthcare settings as an antiseptic, local anesthetic, and sclerosing agent. Clinically, it is included in topical and oromucosal products for temporary relief of minor sore throat pain, sore mouth, canker sore–associated discomfort, and localized irritation. In controlled clinical settings, injectable phenol has been used for chemical neurolysis in the management of focal spasticity.

Phenol exhibits broad antimicrobial activity against many bacteria, select fungi, and certain viruses. Its activity against spores is limited and slow. As a proteolytic agent, concentrations in the 5 to 7 percent range dissolve tissue on contact, contributing to both its antiseptic properties and its capacity for controlled chemical ablation. Injection near peripheral nerves produces nonselective neurolysis, with early-onset local anesthetic effects generally occurring within several minutes.

Absorption occurs readily through intact and damaged skin and mucosa, with rapid distribution and primary hepatic metabolism via conjugation pathways. Excretion is predominantly renal as conjugated metabolites. Systemic exposure is associated with dose-dependent toxicity, and accumulation is possible with repeated high-level contact.

Phenol vapors and solutions are corrosive and can cause severe dermal, ocular, and respiratory injury. Systemic toxicity may manifest as central nervous system depression, cardiovascular instability, or renal impairment following significant exposure. Reproductive toxicity signals have been reported in observational studies citing associations with spontaneous abortion. Phenol has historical misuse in contexts unrelated to therapeutic application; these do not reflect current medical practice.

Commercially, phenol is found in certain throat sprays such as formulations containing 1.4 percent phenol for oromucosal analgesia, as well as products used in podiatric phenolization procedures for ingrown toenails.

For API procurement, sourcing should prioritize material produced under validated chemical synthesis and purification controls, with tight specifications for residual solvents, impurities, and stabilizers due to phenol’s reactivity and toxicity profile. Consistent quality documentation and supply chain traceability are essential.

Identification & chemistry

Generic name Phenol
Molecule type Small molecule
CAS 108-95-2
UNII 339NCG44TV
DrugBank ID DB03255

Pharmacology

SummaryPhenol acts as a potent proteolytic and neurolytic agent, dissolving superficial tissues on contact and disrupting nerve structure at higher concentrations. Its activity involves nonspecific protein denaturation, including interactions with serum albumin and proteases such as thermolysin. These actions produce local anesthetic effects and reduce peripheral nerve signaling relevant to symptomatic relief and focal spasticity management.
Mechanism of actionPhenol is a potent proteolytic agent. Concentrations in the 5% to 7% range dissolve tissue on contact via proteolysis. In high concentrations when injected next to a nerve, phenol produces a chemical neurolysis which is nonselective across nerve fiber size and most prominent on its outer aspect. Local anesthetic effects occur within 5-10 minutes.
Targets
TargetOrganismActions
Serum albuminHumans
ThermolysinBacillus thermoproteolyticus

ADME / PK

AbsorptionPhenol is rapidly absorbed through the skin and into the lungs.
MetabolismPhenyl sulfate, phenyl glucuronide, quinol sulfate, and quinol glucuronide were detected in human beings as phenol metabolites.
Route of eliminationThe kidney is the primary route of elimination of phenol.
Volume of distributionAt I5 min after exposure, the liver contained the highest level of phenol, consisting mainly of free phenol. After 82 minutes post administration, phenol is uniformly distributed in the liver, blood, kidneys, lungs, along with the heart, testes, thymus and the spleen. With the passage of time, the proportion of free to conjugated phenol changed. By 360 minutes most phenol appears in conjugated forms.
ClearanceIn rabbits, 72% is excreted in the urine, 1% in the feces, 4% in the carcass following sacrifice, and trace amounts were exhaled.

Formulation & handling

  • Phenol is a small, highly water‑soluble organic solid commonly formulated as aqueous topical, oral, buccal, and injectable solutions, where solvent choice and pH control are critical for stability and irritation management.
  • Its corrosive and volatile nature requires controlled handling, use of compatible container materials, and attention to evaporation and oxidation during manufacturing and storage.
  • For injectable or submucosal uses, low‑particulate, well‑buffered solutions are needed to limit tissue irritation and ensure consistent local anesthetic or antiseptic performance.

Regulatory status

LifecyclePatent protection in the US and Canada places the API in a **** lifecycle stage, depending on the proximity to final patent expiry. As patents lapse and generic entry becomes possible, the markets are expected to transition toward a more mature, competitive landscape.
MarketsUS, Canada
Supply Chain
Supply chain summaryPhenol is a long‑established chemical ingredient with no single originator; supply is driven by multiple packagers that formulate and distribute it for various therapeutic and consumer uses. Branded products containing phenol are widely available in the US and Canada, indicating broad market penetration without region‑specific exclusivity. Patent protection is not relevant for this mature substance, so generic and multi‑source competition is already fully present.

Safety

ToxicityMouse, Subcutaneous, LD50: 0.3-0.35 g/kg. (Duplay and Cazin, 1891; Tollens, 1905). Rat, Subcutaneous, LD50: 0.45. (Deichmann and Witherup, 1944). Rat, Oral, LD50: 0.53. (Deichmann and Witherup, 1944). Rat, Oral, LD50: 0.65. (Flickinger, 1976). Rat, Cutaneous, LD50: 0.67. (Conning and Hayes, 1970).
High Level Warnings:
  • Acute toxicity is route‑dependent, with reported LD50 values in rodents ranging from ~0
  • 3–0
  • 67 g/kg, indicating significant systemic hazard upon subcutaneous, oral, or dermal exposure

Phenol is a type of Disinfectants


Disinfectants are a crucial subcategory of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a vital role in maintaining cleanliness and preventing the spread of harmful microorganisms. These chemical agents are designed to eliminate or inhibit the growth of bacteria, viruses, fungi, and other pathogens on various surfaces and objects.

Pharmaceutical-grade disinfectants are formulated to meet stringent quality standards and are commonly used in hospitals, laboratories, pharmaceutical manufacturing facilities, and other healthcare settings. They are also utilized in the food and beverage industry, as well as in households, to ensure proper sanitation and hygiene.

Disinfectants typically contain active ingredients such as quaternary ammonium compounds, chlorine compounds, hydrogen peroxide, or alcohol, which have been proven effective against a broad spectrum of microorganisms. These active ingredients work by disrupting the cell membranes or enzymatic processes of the pathogens, rendering them incapable of replication and causing their eventual destruction.

When selecting a disinfectant, factors such as the intended application, target microorganisms, and compatibility with the surfaces or objects being treated need to be considered. It is crucial to follow proper usage instructions and adhere to recommended contact times for effective disinfection.

In conclusion, disinfectants are essential pharmaceutical APIs used to control and prevent the spread of harmful microorganisms. Their efficacy in eliminating pathogens makes them indispensable in maintaining cleanliness and ensuring public health and safety.


Phenol (Disinfectants), classified under Antidotes, Deterrents, and Toxicologic Agents


Antidotes, Deterrents, and Toxicologic Agents are an important category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a critical role in healthcare and toxicology. These substances are designed to counteract the effects of poisons, toxins, and overdoses, thereby saving lives and preventing severe health consequences.

Antidotes are substances that neutralize the toxic effects of certain drugs, chemicals, or poisons. They work by either directly binding to the toxic substance or by blocking its harmful actions on the body. Antidotes are administered in emergency situations to quickly reverse the effects of poisoning and restore normal physiological functions.

Deterrents, on the other hand, are pharmaceutical agents used to discourage or prevent harmful behaviors, such as substance abuse. They are designed to make the ingestion or misuse of certain substances unpleasant or less desirable. Deterrents can be formulated to cause unpleasant side effects, such as nausea or vomiting, when a particular substance is consumed in excessive amounts.

Toxicologic agents encompass a broad range of pharmaceutical APIs used in toxicology studies and research. These substances are employed to investigate the toxicity, metabolism, and mechanisms of action of various chemicals and compounds. Toxicologic agents are vital for understanding the potential hazards and risks associated with certain substances, ensuring the safety of drugs, and developing effective treatments for poisoning cases.

In conclusion, Antidotes, Deterrents, and Toxicologic Agents are essential categories of pharmaceutical APIs that address poisoning emergencies, deter harmful behaviors, and enable toxicological research. Their development and availability are crucial for safeguarding public health, enhancing patient care, and advancing our understanding of toxicology.



Phenol API manufacturers & distributors

Compare qualified Phenol API suppliers worldwide. We currently have 4 companies offering Phenol API, with manufacturing taking place in 4 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Distributor
Germany Unknown BSE/TSE, CoA, GMP, ISO9001, MSDS211 products
Distributor
Netherlands Germany CoA, GMP, ISO9001, MSDS170 products
Producer
United Kingdom United Kingdom CoA, GMP50 products
Distributor
Switzerland Switzerland CoA, GMP, MSDS174 products

When sending a request, specify which Phenol API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Phenol API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.

Frequently asked questions about Phenol API


Sourcing

What matters most when sourcing GMP-grade Phenol?
When sourcing GMP‑grade Phenol, the key considerations are regulatory compliance in the US and Canada and verification that the supplier follows appropriate GMP controls for production and packaging. Because Phenol is a mature, multi‑source ingredient, assessing supplier qualification, documentation, and batch traceability is essential. It is also important to confirm that the material’s specifications and impurity controls meet the intended pharmaceutical use.
Which documents are typically required when sourcing Phenol API?
Request the core API documentation set: GMP (4 companies), CoA (4 companies), MSDS (3 companies), ISO9001 (2 companies), BSE/TSE (1 company). Confirm versions and validity dates match the destination market to avoid delays in qualification.
Which manufacturers are known to produce Phenol API?
Known or reported manufacturers for Phenol: Duchefa Farma B.V., Caesar & Loretz GmbH (CAELO), Hänseler AG, GMP Pharma. Evaluate their GMP history, scale, and regional coverage before requesting dossiers or allocating demand.
How can I request quotes for Phenol API from GMP suppliers?
Submit quote requests through the supplier listings with your specs and required documents (specifications, target volume, delivery timeline, and destination). Providing consistent details upfront speeds comparable offers and clarifies technical feasibility.
Is a GMP audit report available for Phenol manufacturers?
Audit reports may be requested for Phenol: 0 GMP audit reports available. Confirm the scope and recency of any audit before relying on it for qualification decisions.
How many suppliers offer Phenol API on Pharmaoffer?
Reported supplier count for Phenol: 4 verified suppliers. Filter listings by certifications, regions, and delivery options to match your qualification plan.
Which countries are known to manufacture Phenol API?
Production countries reported for Phenol: Germany (1 producer), Switzerland (1 producer), United Kingdom (1 producer). Knowing the manufacturing geography helps anticipate logistics lead times and import compliance needs.
Which certifications do suppliers of Phenol usually hold?
Common certifications for Phenol suppliers: GMP (4 companies), CoA (4 companies), MSDS (3 companies), ISO9001 (2 companies), BSE/TSE (1 company). Always verify issuing authorities and expiry dates when reviewing audit packages.

Technical

What is Phenol (CAS 108-95-2) used for?
Phenol is used as an antiseptic, local anesthetic, and sclerosing agent in topical and oromucosal products for temporary relief of sore throat pain, mouth irritation, and canker sore discomfort. It is also applied in controlled clinical procedures, including chemical neurolysis for focal spasticity and Phenolization for ingrown toenail management. Its activity relies on broad antimicrobial effects and proteolytic tissue ablation.
Which therapeutic class does Phenol fall into?
Phenol belongs to the following therapeutic categories: Anesthetics, Anesthetics, Local, Anti-Infective Agents, Anti-Infective Agents, Local, Antiseptics and Disinfectants. This positioning helps teams compare alternative APIs, anticipate pharmacology expectations, and align early research priorities.
What conditions is Phenol mainly prescribed for?
The primary indications for Phenol: Phenol is primarily indicated for minor sore throat pain, sore mouth, minor mouth irritation, and pain associated with canker sores, Additionally, Phenol is indicated in the treatment of focal spasticity. These use cases frame the target patient populations and help prioritize formulation and safety evaluations.
How does Phenol work?
Phenol is a potent proteolytic agent. Concentrations in the 5% to 7% range dissolve tissue on contact via proteolysis. In high concentrations when injected next to a nerve, Phenol produces a chemical neurolysis which is nonselective across nerve fiber size and most prominent on its outer aspect. Local anesthetic effects occur within 5-10 minutes.
What should someone know about the safety or toxicity profile of Phenol?
Phenol is corrosive and can cause severe skin, eye, and respiratory injury, and it is readily absorbed through intact or damaged tissue, enabling rapid systemic exposure. Systemic toxicity is dose‑dependent and may include central nervous system depression, cardiovascular instability, or renal impairment; reported rodent LD50 values of approximately 0.3–0.67 g/kg reflect its significant acute hazard. Reproductive toxicity signals have been noted in observational studies. Accumulation can occur with repeated high‑level contact, so controlled handling and exposure limits are important.
What are important formulation and handling considerations for Phenol as an API?
Phenol is typically formulated as an aqueous solution, with careful control of solvent composition and pH to maintain stability and limit irritation. Its corrosive and volatile properties require closed, compatible containers and procedures that minimize evaporation and oxidation during manufacturing and storage. For injectable or submucosal applications, solutions should be low in particulates and adequately buffered to reduce tissue irritation and ensure consistent performance.
Is Phenol a small molecule?
Phenol is classified as a small molecule. That classification shapes process design, impurity profiling, and analytical control strategies.
Are there special stability concerns for oral Phenol?
Oral Phenol solutions require tight control of solvent composition and pH, as these factors influence chemical stability and local irritation. Phenol’s volatility and corrosive nature make it prone to evaporation and oxidative degradation, so compatible containers and minimized headspace are important. Attention to handling and storage conditions is needed to limit loss of potency and maintain a consistent solution.

Regulatory

Where is Phenol approved or in use globally?
Phenol is reported as approved in the following major regions: US, Canada. Understanding geographic coverage informs regulatory filings, supply planning, and risk assessments before escalating procurement.
What’s the regulatory and patent landscape for Phenol right now?
Phenol is subject to established chemical and pharmaceutical regulatory controls in the US and Canada, where its quality and handling requirements are defined by national standards. Both regions treat it as a controlled industrial and pharmaceutical substance with specified purity and safety expectations. No patent‑related information is provided in the available context.

Pharmaoffer

How does Pharmaoffer’s Smart Sourcing Service help with Phenol procurement?
Pharmaoffer's Smart Sourcing Service coordinates compliant suppliers, documentation, and competitive quotes for Phenol. It centralizes outreach, follow-ups, and document validation to shorten procurement timelines.
Is Phenol included in the PRO Data Insights coverage?
PRO Data Insights coverage for Phenol: 154618 verified transactions across 13149 suppliers and 9094 buyers worldwide. Use the dataset to benchmark suppliers and monitor regulatory activity where available.
Where can I access the API market report for Phenol?
Market report availability for Phenol: Report Available. The report highlights demand trends, pricing drivers, and supplier landscape insights for procurement planning.